Jon E. Angell

Array ( [id] => 7045591 [patent_doc_number] => 20050250186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression' [patent_app_type] => utility [patent_app_number] => 10/140776 [patent_app_country] => US [patent_app_date] => 2002-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11829 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250186.pdf [firstpage_image] =>[orig_patent_app_number] => 10140776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783504 [patent_doc_number] => 20030064952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis' [patent_app_type] => new [patent_app_number] => 10/141647 [patent_app_country] => US [patent_app_date] => 2002-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 19564 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064952.pdf [firstpage_image] =>[orig_patent_app_number] => 10141647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1213085 [patent_doc_number] => 06710037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-23 [patent_title] => 'Method of treating androgen-dependent disorders' [patent_app_type] => B2 [patent_app_number] => 10/137057 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7935 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/710/06710037.pdf [firstpage_image] =>[orig_patent_app_number] => 10137057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 843439 [patent_doc_number] => 07387900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-17 [patent_title] => 'Colloidal metal compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/135886 [patent_app_country] => US [patent_app_date] => 2002-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 22 [patent_no_of_words] => 20736 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/387/07387900.pdf [firstpage_image] =>[orig_patent_app_number] => 10135886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814107 [patent_doc_number] => 20030073657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an ACT polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances' [patent_app_type] => new [patent_app_number] => 10/135629 [patent_app_country] => US [patent_app_date] => 2002-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18582 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073657.pdf [firstpage_image] =>[orig_patent_app_number] => 10135629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6830347 [patent_doc_number] => 20030181405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Interferon alpha plasmids and delivery systems, and methods of making and using the same' [patent_app_type] => new [patent_app_number] => 10/136837 [patent_app_country] => US [patent_app_date] => 2002-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 27059 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181405.pdf [firstpage_image] =>[orig_patent_app_number] => 10136837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869494 [patent_doc_number] => 20030082183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Methods and compositions for treatment of ocular neovascularization and neural injury' [patent_app_type] => new [patent_app_number] => 10/020541 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5732 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082183.pdf [firstpage_image] =>[orig_patent_app_number] => 10020541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874095 [patent_doc_number] => 20030194392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA' [patent_app_type] => new [patent_app_number] => 10/122114 [patent_app_country] => US [patent_app_date] => 2002-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17582 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20030194392.pdf [firstpage_image] =>[orig_patent_app_number] => 10122114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6258619 [patent_doc_number] => 20020187126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Methods for viral oncoapoptosis in cancer therapy' [patent_app_type] => new [patent_app_number] => 10/118655 [patent_app_country] => US [patent_app_date] => 2002-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15609 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187126.pdf [firstpage_image] =>[orig_patent_app_number] => 10118655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4460005 [patent_doc_number] => 07879606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Compositions and methods useful for HCV infection' [patent_app_type] => utility [patent_app_number] => 10/109298 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8072 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879606.pdf [firstpage_image] =>[orig_patent_app_number] => 10109298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307582 [patent_doc_number] => 07531648 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Vector encoding an antibody that binds 5T4 antigen' [patent_app_type] => utility [patent_app_number] => 10/104522 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 21545 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531648.pdf [firstpage_image] =>[orig_patent_app_number] => 10104522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6405708 [patent_doc_number] => 20020182626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Episomal non-transforming nucleic acid elements in functional genomic and antigenic applications' [patent_app_type] => new [patent_app_number] => 10/098606 [patent_app_country] => US [patent_app_date] => 2002-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21345 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182626.pdf [firstpage_image] =>[orig_patent_app_number] => 10098606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 472360 [patent_doc_number] => 07229841 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Colloidal metal compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/093578 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 10 [patent_no_of_words] => 20696 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/229/07229841.pdf [firstpage_image] =>[orig_patent_app_number] => 10093578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6412889 [patent_doc_number] => 20020183253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Method of treating ocular neovascularization' [patent_app_type] => new [patent_app_number] => 10/080797 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11837 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183253.pdf [firstpage_image] =>[orig_patent_app_number] => 10080797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851977 [patent_doc_number] => 20030144180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Methods and pharmaceutical compositions for healing wounds' [patent_app_type] => new [patent_app_number] => 10/077792 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19040 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144180.pdf [firstpage_image] =>[orig_patent_app_number] => 10077792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797797 [patent_doc_number] => 20030176671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Apoptosis modulator BCL-B and methods for making and using same' [patent_app_type] => new [patent_app_number] => 10/071174 [patent_app_country] => US [patent_app_date] => 2002-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22508 [patent_no_of_claims] => 141 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176671.pdf [firstpage_image] =>[orig_patent_app_number] => 10071174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847062 [patent_doc_number] => 20030166229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Human POSH-like protein 1' [patent_app_type] => new [patent_app_number] => 10/061201 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 38379 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166229.pdf [firstpage_image] =>[orig_patent_app_number] => 10061201 [rel_patent_id] =>[rel_patent_doc_number] =>)